NewsMar 18, 2022EXPLAINER: What to Know About the ‘Deltacron’ Hybrid Coronavirus VariantUS News & World Report
ResearchMar 15, 2022SARS-CoV-2 variant Delta rapidly displaced variant Alpha in the United States and led to higher viral loadsCELL REPORTS MEDICINE
NewsMar 13, 2022‘Deltacron,’ the Delta-Omicron hybrid COVID variant, appears to be in the U.S., according to a new studyFortune
NewsMar 10, 2022Public-Private Partnerships are Key to Improving America's Pandemic Response Now and in the FutureNasdaq
Press ReleasesMar 7, 2022HealthPartners, Helix partner to help create DNA testing program that helps families better understand their genetic health
Blog From Niche to Necessity: Precision Medicine Isn’t an Initiative. It’s the New Infrastructure.By James Lu, MD, PhD, CEO and Co-Founder of Helix
Press ReleasesHelix GenoSphere™ Launches MASH-Enriched Cohort of Over 17,000 Linked Clinico-Genomic Records to Accelerate Drug Discovery and DevelopmentOctober 15, 2025
Press ReleasesHelix to Present New Population-Scale Genomic Research at ASHG 2025 Annual MeetingOctober 7, 2025
VideosPartner Perspectives with Nebraska MedicineGenetic Insights Project helps Nebraskans take charge of their health
1Published ResearchPopulation Genomic Screening and Improved Lipid Management in Patients With Familial HypercholesterolemiaNovember 5, 2025
2Published ResearchFrom Uncertain to Actionable: Significant Reduction in Variants of Uncertain Significance in Hereditary Germline Testing via Multi-Institutional Real-World EvidenceAugust 15, 2025
3Published ResearchNovel Method for Predicting Lp(a) From Genomic Testing Identifies ASCVD Risk Across a Diverse CohortJuly 30, 2025
4Published ResearchChatbot for the Return of Positive Genetic Screening Results for Hereditary Cancer Syndromes: Prompt Engineering ProjectJune 10, 2025
5Published ResearchIndividuals with PMS2 pathogenic variants are at average risk of cancer before age 60March 19, 2025
Blog From Niche to Necessity: Precision Medicine Isn’t an Initiative. It’s the New Infrastructure.By James Lu, MD, PhD, CEO and Co-Founder of Helix
Press ReleasesHelix GenoSphere™ Launches MASH-Enriched Cohort of Over 17,000 Linked Clinico-Genomic Records to Accelerate Drug Discovery and DevelopmentOctober 15, 2025
Press ReleasesHelix to Present New Population-Scale Genomic Research at ASHG 2025 Annual MeetingOctober 7, 2025
VideosPartner Perspectives with Nebraska MedicineGenetic Insights Project helps Nebraskans take charge of their health
1Published ResearchPopulation Genomic Screening and Improved Lipid Management in Patients With Familial HypercholesterolemiaNovember 5, 2025
2Published ResearchFrom Uncertain to Actionable: Significant Reduction in Variants of Uncertain Significance in Hereditary Germline Testing via Multi-Institutional Real-World EvidenceAugust 15, 2025
3Published ResearchNovel Method for Predicting Lp(a) From Genomic Testing Identifies ASCVD Risk Across a Diverse CohortJuly 30, 2025
4Published ResearchChatbot for the Return of Positive Genetic Screening Results for Hereditary Cancer Syndromes: Prompt Engineering ProjectJune 10, 2025
5Published ResearchIndividuals with PMS2 pathogenic variants are at average risk of cancer before age 60March 19, 2025